707 related articles for article (PubMed ID: 15467532)
1. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
2. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
[TBL] [Abstract][Full Text] [Related]
3. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
5. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
6. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Rosenblatt KA; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
[TBL] [Abstract][Full Text] [Related]
7. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
[TBL] [Abstract][Full Text] [Related]
8. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
[TBL] [Abstract][Full Text] [Related]
11. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
Riman T; Nilsson S; Persson IR
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
[TBL] [Abstract][Full Text] [Related]
12. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for ovarian cancer in central Italy.
Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for benign serous and mucinous epithelial ovarian tumors.
Jordan SJ; Green AC; Whiteman DC; Webb PM
Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
[TBL] [Abstract][Full Text] [Related]
16. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
17. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
Narod SA; Risch H; Moslehi R; Dørum A; Neuhausen S; Olsson H; Provencher D; Radice P; Evans G; Bishop S; Brunet JS; Ponder BA
N Engl J Med; 1998 Aug; 339(7):424-8. PubMed ID: 9700175
[TBL] [Abstract][Full Text] [Related]
19. Gender of offspring and maternal ovarian cancer risk.
Gierach GL; Modugno F; Ness RB
Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
[TBL] [Abstract][Full Text] [Related]
20. Tubal ligation and the risk of ovarian carcinoma.
Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
